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Abstract
Lack of capacity to cross the nucleus membrane seems to be one of the main reasons for
the lower transfection efficiency of gene vectors observed in vivo study than in vitro. To
solve this problem, a new non-viral gene vector was designed. First, a degradable polyethy-
lenimine (PEI) derivate was synthesized by crosslinking low-molecular-weight (LMW) PEI
with N-octyl-N-quaternary chitosan (OTMCS), and then adopting a designed trifunctional
peptide (RGDC-TAT-NLS) with good tumor targeting, cell uptake and nucleus transport
capabilities to modify OTMCS-PEI. The new gene vector was termed as OTMCS-PEI-R18
and characterized in terms of its chemical structure and biophysical parameters. Gene
transfection efficiency and nucleus transport mechanism of this vector were also evaluated.
The polymer showed controlled degradation and remarkable buffer capabilities with the par-
ticle size around 100–300 nm and the zeta potential ranged from 5 mV to 40 mV. Agraose
gel electrophoresis showed that OTMCS-PEI-R18 could effectively condensed plasmid
DNA at a ratio of 1.0. Besides, the polymer was stable in the presence of sodium heparin
and could resist digestion by DNase I at a concentration of 63U DNase I/DNA. OTMCS-PEI-
R18 also showed much lower cytotoxicity and better transfection rates compared to poly-
mers OTMCS-PEI-R13, OTMCS-PEI and PEI 25 KDa in vitro and in vivo. Furthermore,
OTMCS-PEI-R18/DNA complexes could accumulate in the nucleus well soon and not rely
on mitosis absolutely due to the newly incorporated ligand peptide NLS with the specific
nuclear delivery pathway indicating that the gene delivery system OTMCS-PEI-R18 could
reinforce gene transfection efficiency in vivo.
Introduction
Cancer remains a global health problem and a major cause of death worldwide. Statistical anal-
ysis published by the International Agency for Research on Cancer from WHO reveals that if
the estimated trends continue, the incidence of all cancer cases will raise from 12.7 million
PLOS ONE | DOI:10.1371/journal.pone.0166673 December 9, 2016 1 / 21
a11111
OPENACCESS
Citation: Hu J, Zhu M, Liu K, Fan H, Zhao W, Mao
Y, et al. (2016) A Biodegradable Polyethylenimine-
Based Vector Modified by Trifunctional Peptide
R18 for Enhancing Gene Transfection Efficiency In
Vivo. PLoS ONE 11(12): e0166673. doi:10.1371/
journal.pone.0166673
Editor: Maria Gasset, Consejo Superior de
Investigaciones Cientificas, SPAIN
Received: March 13, 2016
Accepted: November 2, 2016
Published: December 9, 2016
Copyright: © 2016 Hu et al. This is an open access
article distributed under the terms of the Creative
Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in
any medium, provided the original author and
source are credited.
Data Availability Statement: All relevant data are
within the paper.
Funding: This work was supported by the National









new cases in 2008 to 21.2 million by 2030 [1]. Facing such an alarming disease progression,
varieties of therapies have been developed but expected efficiency has still not been reached.
Cancer is a genetic disease induced by many factors [2]. The process of neoplastic cell apopto-
sis and its regulation and control factors are the hotspot of investigation in recent years. Gene
therapy is tried to be realized through inducing cell apoptosis [3]. On one hand, gene therapy
is considered to be a safe and effective treatment by using exogenous nucleic acids as therapeu-
tic agents, which has the potential to depress oncogenes and restrain the proliferation of intrac-
table tumors and has no effect on normal cells. However, the easy degradation in biological
fluids and the low cellular uptake efficiency of nucleic acids cause gene therapy strongly subject
to the development of gene vectors [4]. All in all, gene transfection is the key technique of gene
therapy. At present, more and more attention is focused on non-viral vectors [5]. Polyethyleni-
mine (PEI) is a kind of typical cationic polymer which has large amount of positive charge can
form condensed complex with DNA spontaneously through electrostatic interactions. Due to
its highly effective gene transfection, PEI has gained a remarkable interest in the field of non-
viral gene delivery system [6–8]. However, testing of PEI vectors in preclinical studies identi-
fied several drawbacks: the contradiction between toxicity and transfection efficiency, lacking
of specific tumor targeting ability, low transfection capacity in vivo.
Chitosan is a natural cationic non-toxic polysaccharide, which has been regarded as a fasci-
nated candidate for transfection as it is biodegradable and biocompatible [9]. This attribute
has been fully reflected in chitosan-mediated gene transfection systems. However, several
problems need to be solved before practical application such as insolubility at physiological
pH, and low transfection efficiency in particular [10].
It has been proved that PEI derivatives obtained by cross-linking low-molecular-weight
(LMW) PEI with degradable materials display higher transfection efficiency and lower cyto-
toxicity [11,12]. To salve the conflict between the high cytotoxicity and low transfection effi-
ciency of gene vector, a new polymer has been synthesized by covalent linkage between the
activated chitosan OTMCS and non-toxic low molecularPEI (2 KDa) firstly, and was named
OTMCS-PEI. As what we have reported in that paper, OTMCS-PEI revealed lower cytotoxic-
ity for the property of degrading into small molecules after uptake into the cells. However, the
transfection efficiency of the polymeric gene vector is not high enough and it was worth
improving its tumor targeting [13].
The strategy for incorporating ligand peptide with favorite characteristics into target mole-
cules has been the most considerable method in developing target specific non-viral gene
delivery systems [14]. Integrin αvβ3 receptor is highly expressed in tumor cells whereas rarely
detectable on quiescent blood vessels. This character allows for its use as a suitable target for
gene vector. Knowing that arginine-glycine-aspartate-cysteine (RGDC) peptide is a key bind-
ing moiety that has been shown to bind specifically to αvβ3 integrin receptors [15,16].
Cell membrane prevents xenobiotic from entering unless an active transport mechanism
involved, which happens mainly with specific peptides. TAT peptide is one of the protein-
derived peptides, which has been reported capable of facilitating the cellular uptake of macro-
molecular particles. The commonly used transduction domain of TAT extends from residues
47–57: Arg-Lys-Lys-Arg-Arg-Gln-Arg-Arg-Arg [17,18]. Therefore, we used RGDC peptide
conjunction with TAT to yield a new chimeric peptide RGDC-NLS (named R13), and bifunc-
tional peptide R11 to modify PEI derivates respectively, in order to improve cell selection, pro-
mote cargo transport and enhance transfection efficiency.
The polymer OTMCS-PEI-R13 has showed low cytotoxicity as OTMCS-PEI, and higher
transfection in vitro. With the following in vivo studies, gene transfection efficiency was found
to be much lower compared with in vitro. The main reason is that the transport manner of
complexes across nucleus membrane in vivo is different from in vitro. DNA complexes get
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into nucleus via mitosis in vitro as tumor cells are in division phase, while most of the target
cells in vivo are non-dividing, which makes it more difficult for gene transport. Lack of capac-
ity to cross the nucleus membrane seems to be the principle cause of the low transfection effi-
ciency observed in vivo study [19].
It is one of the major limitations for plasmid DNA to entry into the nucleus from the cyto-
plasm. Several groups have demonstrated that the attachment of a nuclear localization
sequence (NLS) either directly to DNA or to polymers that form complexes with DNA lead to
an increased nuclear import of DNA [20,21], especially in vivo tranfection with the non-divid-
ing cells, resulting in enhanced protein expression. Talsma has declared that PEI conjugated to
σ1-NLS performed substantially better as a transfection agent than PEI alone. With σ1-NLS,
69% of the internalized protein was recovered in the nuclear fraction after 6 h compared to
just 10% when using unmodified σ1. At the same time, transfection of cells with PEI-σ1-
NLS-DNA complexes resulted in an average 16-fold increase in luciferase activity compared to
cells transfected with PEI-DNA. These results suggested that σ1-NLS is an efficient targeting
ligand for non-viral gene delivery system based on PEI [22]. Macromolecule mediated by NLS
is actively transported to nucleus via nuclear pore complex (NPC), and NLS of SV40 T-antigen
with the major functional sequence Lys-Lys-Lys-Arg-Lys (KKKRK) was discovered firstly and
has been the major research object. Therefore, we used the linear peptide R13 (RGDC-TAT),
in conjunction with NLS to yield a novel peptide, RGDC-TAT (49–57)-NLS, named R18. The
trifunctional R18 can adhere to tumor cells by targeting to αvβ3 receptors, facilitate the cellular
uptake and nuclear transport of polyplexes. Then we adopted R18 to modify OTMCS-PEI to
prepare a new non-viral gene vector (OTMCS-PEI-R18). The new gene vector was character-
ized in terms of its chemical structure and biophysical parameters. Gene transfection efficiency
of this vector was validated by in vitro and in vivo studies. Chemical inhibitors specific to vari-
ous intracellular pathways and confocal laser scanning microscopy have been applied to inves-
tigate its nuclear transport. The purpose of the present study was to find a gene vector with
low cytotoxicity and high transfection efficiency in vivo.
Materials and Methods
Materials
Chemicals. Branched PEI 2KDa, 3-(4, 5-dimethyl-2-thiazolyl)-2, 5-diphenyl tetrazolium
bromide (MTT) and heparin were purchased from Sigma-Aldrich. Chitosan 2KDa (degree of
deacetylation, 90%), dichloromethane, benzene, triethylamine, triphosgene, ethyl acetate, N-
hydroxysuccinimide and absolute ethyl alcohol were purchased from Sinopharm Chemical
Reagent Co, Ltd. DNase I was obtained from the Worthington Company. Dialysis bag
(MWCO 7000) was purchased from Spectrum Chemical & Instruments. Paclitaxel (PTX),
Hochest 33258 and fluorescein isothiocynate (FITC) were purchased from Sigma Aldrich. 4%
paraformaldehyde was provided by Beijing Solarbio Science & Technology Co. Ltd. Colchicine
(Col) and acrylamide were purchased from Beijing Hotaibio Science & Technology Co.
Plasmids. The plasmid encoding the enhanced green fluorescent protein (pEGFP-N2)
was kindly supplied by Tongji University. The purity of the purified and concentrated DNA
was determined by measuring its UV absorbance value at 260 nm and 280 nm respectively.
Luciferase assay system for transfection and pGL3-Control vector modified with SC-40 pro-
moter and enhancer encoding firefly luciferase were obtained from Promega Corp. The plas-
mids were amplified by Escherichia coli DH5α and prepared using the Tiangen End-free
Plasmid Mega Kit according to the manufacturer’s specifications.
Peptide. The oligopeptide Arg-Gly-Asp-Cys-Arg-Lys-Lys-Arg-Arg-Gln-Arg-Arg-Arg-
Lys-Lys-Lys-Arg-Lys (R18, MW 2439.99 Da) was synthesized by GL Biochem (Shanghai,
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China), and the amino acid sequence and purity were detected by mass spectroscopy and high
performance liquid chromatography.
Cell culture. The Hela cell line was purchased from the Type Culture Collection of the
Chinese Academy of Sciences, Shanghai, China. Culture medium (RPMI 1640) and fetal
bovine serum (FBS) were purchased from GIBCO.
Animals. Athymic nude mice (males, 4–6 weeks old, 16–18 g) were purchased from the
National Rodent Laboratory Animal Resources, Shanghai Branch (Shanghai, China). Animals
were housed in a barrier facility on a high efficiency particulate arrestance (HEPA)-filtered
rack under standard conditions of 12-hour light/dark cycles. The animals were fed an auto-
claved laboratory rodent diet. All mouse surgical procedures were performed with the animals
anesthetized by intramuscular injection of 50% ketamine, 38% xylazine, and 12% aceproma-
zine maleate (0.02 ml). The maximum tumor size was less than 2 cm. The condition of the ani-
mals was monitored every day. Some animals did become severely ill and even died after being
injected with Hela cells for establishing tumor model. These animals that became severely ill
were treated with high concentration of carbon dioxide for euthanasia. The animals were all
sacrificed 24 hours after giving doses. CO2 inhalation was used for euthanasia. To ensure
death following CO2 asphyxiation, cervical dislocation was performed. All animal procedures
were approved by the Committee for Animal Research of Shanghai Ocean University, China
(SCXK (HU) 2007–0003) and carried out according to the Guide for the Care and Use of Lab-
oratory Animals.
Synthesis and characterization of OTMCS-PEI-R18
OTMCS and OTMCS-PEI were synthesized according to the method described in our previ-
ous work. Polymer OTMCS-PEI was conjugated with peptide using SMCC as crosslinker.
Firstly, dimethyl sulfoxide (DMSO) was used as stock solution to prepare 3.33 mg/mL SMCC
solution, and then the prepared solution was added dropwise into OTMCS-PEI solution (10
mg/mL in PBS) at 2:1, 10:1 mole ratios with constant stirring at room temperature for 30 min.
After complete reaction, the excessive non-conjugated crosslinker was removed by gel
chromatography (Sephadex G-25, Pharmacia, Milton Keynes, UK) that had been equilibrated
with PBS (0.1M, pH 7.4). Then, trifunctional peptide R18 solution (using 0.1 M PBS as solvent
to10 mg/mL) was added dropwise into prepared OTMCS-PEI solution with gently stirring at
4˚C overnight in the dark, R18 was reacted with the maleimide-actived OTMCS-PEI at a
molar ratio of 2:1 and 10:1. The product was obtained by lyophilization after removing the
excessive unreacted R18 by ultrafiltration with Amicon Ultra-4 centrifugal filter devices (Milli-
pore, Billerica, MA). Finally, two types of cationic polymer were obtained and named OTMC-
S-PEI-R18-l and OTMCS-PEI-R18-h, respectively.
The structure of OTMCS-PEI-R18 was characterized by 1H nuclear magnetic resonance
(1H NMR) spectra. 10 mg of OTMCS-PEI-R18 was dissolved in 0.6 mL of deuterium oxide
(D2O) in an NMR tube, and the
1H NMR spectrum was recorded using a Varian 300 MHz
spectrometer (Varian Medical Systems Inc, Palo Alto, CA) at room temperature.
Degradation of OTMCS-PEI-R18
Degradation of OTMCS-PEI-R18 was estimated by the measurement of molecular weight at
different time. 0.5 g of the polymers were dissolved in 10 mL of PBS (0.1M, pH 7.4) and incu-
bated at 37˚C with shaking at 100 rpm for different time, then solutions of the polymers were
lyophilized and the molecular weights of lyophilized samples were measured by GPC-MALLS
with 690 nm laser wavelength using TSK-GEL G5000PWxL (temperature 30˚C, pressure
1.58Mpa) operated at a flow rate of 0.5mL/min.
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Buffering capacity of the OTMCS-PEI-R18 polymer
The synthesized OTMCS-PEI-R18 polymer solution was prepared in a 50 mL flask (0.2 mg/
mL, 30 mL), using pure water as control. After adjusting the initial pH to 10.0 with 0.1 M
NaOH, 25μL increment of 0.1 M HCl was added, and the pH of the solution was measured
with a pH meter after each addition [23].
Particle size and Zeta potential measurements
Particle size and zeta potential of OTMCS-PEI-R18/DNA complexes were measured by an
electrophoretic light-scattering spectrophotometer (Zetasizer Nano ZS90, MAN0317 Issue 5.0,
Malvern Instruments Ltd. Malvern,UK), with a 90˚ scattering angle in PBS buffer at room tem-
perature. The complexes were prepared at desired w/w ratios ranging from 5 to 40 with incu-
bating for 30 min at room temperature, and then measured for size and zeta potential. All the
experiments were performed in triplicate.
Agarose gel retardation assay
The DNA complex ability of OTMCS-PEI-R18 was confirmed by agarose gel retardation
experiment. Polymer/DNA complexes at different weight ratios were prepared with the plas-
mid DNA concentration of 25 ng/μL. Then applied mixed liquor of 5 μL of complexes solution
and 1 μL of 5× loading buffer to 1% agarose gel. After electrophoresis was carried out in Tris-
Acetate-EDTA (TAE) buffer at 160 V for 30 min, the gel was stained with 0.5 μg/mL ethidium
bromide for about 10 min at room temperature and illuminated by an UV illuminator to show
the location of the DNA.
Resistance to DNase I digestion
Adding different amount of DNase I to 10 μL of polymer/DNA complexes solution (250 ng of
plasmid DNA) in 0.5 mL Eppendorf tubes and incubated at 37˚C for 30 min. Then adding
2 μL of EDTA (250 mM) and incubated at room temperature for 10 min to inactivate the
enzyme. Finally, 10 μL of sodium heparin (2 mg/mL) was added and incubated at room tem-
perature for 2 h to dissociate the complexes. After all of these steps, electrophoresis was con-
ducted as the method above to evaluate the resistance to DNase I digestion.
Resistance to sodium heparin
10 μL of polymer/DNA complexes solution (250 ng of plasmid DNA) was prepared in 0.5 mL
eppendorf tubes, 2 μL of sodium heparin solution of different concentration was added to the
tubes. After incubation at 37˚C for 60 min (30 min for the latter), electrophoresis was con-
ducted to evaluate the resistance of OTMCS-PEI-R18 to sodium heparin.
Cell lines and culture conditions
Hela (cervical cancer line, adherent) were grown in RPMI 1640 medium (Gibco) supplemented
with 10% (v/v) FBS. They were incubated at 37˚C in a humidified atmosphere of 5% CO2.
Cytotoxicity assay
The cell viability of Hela cells after treatment with OTMCS-PEI-R18 were determined by MTT
assay [24]. The cells were seeded at a density of 5000 cells per well with 200 μL of growth
medium in 96-well plates and incubated for 24 h to reach 80% confluence. Thereafter, they
were treated with different concentrations of polymer (4 μg/mL, 8 μg/mL, 16 μg/mL, 24 μg/
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mL, 32 μg/mL) dissolved in fresh serum-free medium. 4 h later, the medium was replaced by
200 μL of fresh growth medium. After 72 h incubation, the medium was removed and 20 μL of
MTT solution (5 mg/mL) and 180 μL of fresh growth medium were added to each well and
incubated for 4 h at 37˚C in a CO2-incubator. Then medium was removed and 150 μL of
DMSO was added to dissolve any formazon crystals formed. Control groups were used in
which cells without any treatment (culture medium + cells). To evaluate cell viability, the
absorbance value at 490 nm and 570 nm was measured by an ELISA plate reader with back-
ground subtraction. The cell viability (%) was calculated according to the following equation:
Cell viability (%) = (Atest/Acontrol) × 100 (mean ± standard deviation, n = 6)
Where Atest is the absorbance of OTMCS-PEI-R18 treated cells and Acontrol is the absor-
bance of the untreated cells.
In vitro gene transfection
The plasmid pEGFP-N2 and pGL3-Control were used to measure the gene transfection effi-
ciency of OTMCS-PEI-R18. Hela cells were cultured in 24 well plates with medium containing
10% FBS. Cells were grown to 80% confluence before transfection. For transfection, cells were
washed twice with PBS and exposed to polymer/DNA condensates suspended in medium
without FBS, the weight ratio of polymer and DNA was set as 5, 10, 20, 30 (2.5 μg of plasmid
DNA per well). Accordingly, the concentrations of polymers were 12.5 μg/mL, 25 μg/mL,
50 μg/mL, 75 μg/mL respectively. The plates were incubated at 37˚C for 4 h. Then the wells of
plates were rinsed thoroughly with PBS and filled with 1 mL of culture medium with 10% FBS
and incubated at 37˚C for 48 h. After transfection for 48 h, the pEGFP-N2 expression was
observed with an inverted fluorescent microscope (AE-31, Motic Corporation, Wetzlar, Ger-
many). Luciferase gene expression was measured by a luminescence assay. After transfection
for 48 h, the culture medium was discarded and cell lysate was harvested after gentle shaken of
cells in 200 μL of cell culture lysis reagent (CCLR) for 15 min at room temperature. The lysate
was centrifuged for 5 min at 14,000 rpm at 4˚C. 20 μL of supernatant was diluted into 100 μL
of luciferase reaction buffer (Promega) and luciferase activity was measured with a lumin-
ometer (Turner Designs Luminometer Model TD-20/20, Promega). The relative light units
(RLUs) were normalized against protein concentration in the cell extracts, which was mea-
sured using a BCA protein assay kit (Pierce, Rockford, IL) [25].
Determination of confocal laser scanning microscopy
The in vitro cellular uptake was determined by confocal laser scanning microscopy. OTMC-
S-PEI-R18 was labeled with FITC firstly. Hela cells were seeded into six-well plates within cell
coverslip pre-paved at a density of 5×105 cells per well and incubated for 12 h to obtain
approximately 60% cell confluence. Then the cells were incubated with 1640 medium contain-
ing FITC-labeled OTMCS-PEI-R18 /DNA complexes for 0.5 h, 1 h and 2 h respectively. After
that, the medium was removed and cells were fixed with 4% paraformaldehyde for 30 min and
stained with 10 μg/mL Hochest 33528 for 15 min. Cells were rinsed 3 times with PBS after
every step to remove the surface-associated complex and free reagent. Subsequently cell cover-
slip was placed on microscope slide with a drop of Anti fluorescent quenching agent, and the
intracellular distribution of complexes was analyzed by confocal laser scanning microscope
(CLSM, Olympus, FV1000-IX81,Japan) [26–28].
Nuclear transport capability
Chemical inhibitors have an enormous impact on the intracellular components and structure,
and then affect the transfection processing of complexes. PTX is initially characterized as a
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PLOS ONE | DOI:10.1371/journal.pone.0166673 December 9, 2016 6 / 21
mitotic inhibitor, and its anti-neoplastic effect is derived from binding to tubulin and excessive
microtubule stabilization. PTX is immunostimulatory against tumors and also regulates lym-
phocyte activation suggesting that apart from promoting inhibition in cell division [29]. Col-
chicine principally is a microtubule inhibitor, thus prevents cell migration, division, and
polarization [30]. Acrylamide is a known disrupter of intermediate filaments [31].
In this study, Hela cells were treated with microtubule inhibitors Colchicine (Col), Pacli-
taxel (PTX) and intermediate filament inhibitor Acrylamide to inhibit cell division, gene trans-
fection efficiency decreased as the DNA complexes couldn’t get into nucleus via cell division.
The impacts of these inhibitors on transfection efficiency of OTMCS-PEI/DNA, OTMC-
S-PEI-R13/DNA and OTMCS-PEI-R18/DNA were different as the distinguishing features of
the ligand being modified, which reflected the nucleus transport capability of the ligand. The
effects of these inhibitors were investigated using the pGL3-Control reporter gene. All of the
experiment methods refer to 2.10, except for the difference that before transfection, the culture
medium was replaced with 400 μL of serum-free RPMI 1640 medium containing different
concentrations of inhibitors and incubated for 30 min.
In vivo gene transfection
Athymic nude mice (males, 4–6 weeks old, 16–18 g) were used for detecting gene transfection
efficiency of OTMCS-PEI-R18, OTMCS-PEI-R13, OTMCS-PEI in vivo. These mice were
divided into five groups (5 mice per group). 2 × 106 Hela cells suspended in 0.2 mL of physio-
logical saline were injected subcutaneously into each mouse to develop tumor models [32,33].
Two weeks later, when the mean longitudinal diameters of the subcutaneously transplanted
tumor reached 10 mm, 250 μL of sterile polymer/DNA complexes solution containing 30 μg of
the pGL3-Control reporter gene was injected into the tail vein of each mouse. Detailed opera-
tion are as followed: Group 1, OTMCS-PEI-R18-l/DNA complexes, w/w 30. Group 2, OTMC-
S-PEI-R18-h/DNA complexes, w/w 30. Group 3, OTMCS-PEI-R13/DNA complexes, w/w 10.
Group 4, OTMCS-PEI/DNA complexes, w/w 30. Group 5, PEI 25 KDa/DNA complexes, w/w
30.
24 hours later, 5 mice of each group were sacrificed by euthanasia, the major tissues (heart,
liver, spleen, lung, kidney) and the subcutaneously transplanted tumors were removed. These
tissues and tumors were collected, ground and homogenized in cell culture lysis reagent
(CCLR). The cell lysate was centrifuged for 10 min at 9,800 rpm. Luciferase activity was mea-
sured with a luciferase assay kit in a signal-well luminometer. The RLUs were detected against
protein concentration in the cell tissue extracts, which was measured with the a BCA protein
assay kit (Pierce, Rockford, IL).
Results and Discussion
Synthesis and characterization of OTMCS-PEI-R18
The degradable PEI derivates of OTMCS-PEI were synthesized by linking PEI 2 kDa with
OTMCS and then conjugated with a trifunctional peptide R18 to prepare a new nonviral gene
delivery vector OTMCS-PEI-R18 (Fig 1). As for OTMCS-PEI, the free hydroxyl groups of
OTMCS were activated by succinimidyl carbonate in advance and then linked to the amino
groups of PEI. SMCC was used as a crosslinker to conjugate OTMCS-PEI with R18.
Fig 2A exhibited the 1H NMR spectra of OTMCS-PEI in D2O, where the glucosamine pro-
ton peaks appear at 3.136 ppm. Fig 2B exhibited the 1H NMR spectra of OTMCS-PEI-R18 in
D2O. Comparing OTMCS-PEI with OTMCS-PEI-R18, the proton peaks of OTMCS-PEI-R18
moved to the lower magnet field due to the production of the groups with electronic screening
effect from R18. The performances of characteristic peaks have changed, the proton peaks at
A Biodegradable Gene Vector for In Vivo Gene Transfection
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Fig 1. Synthesis and putative structure of OTMCS-PEI-R18.
doi:10.1371/journal.pone.0166673.g001
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2.719–2.824 ppm depressed and the peak value at 1.422 ppm decreased indicating that OTMC-
S-PEI-R18 was successfully prepared.
OTMCS-PEI and OTMCS-PEI-R18 were further characterized using MALDI-TOF (Fig 3A
and 3B). Due to the high polydispersity of our polymers and the resulting mass discrimination
against high-mass oligomers in the MALDI-TOF spectra [34], the molecular weight distribu-
tion of OTMCS-PEI and OTMCS-PEI-R18 can hardly be accurately determined using the
results. However, compared with the position of the peaks in the spectrum of OTMCS-PEI,
peaks in the spectrum of OTMCS-PEI-R18 have been shifted towards the higher mass rang.
Such a shift indicated that the molecular mass of OTMCS-PEI-R18 is higher than OTMC-
S-PEI, suggesting successful cross-linking of OTMCS-PEI with R18 by SMCC.
Buffering capacity of the OTMCS-PEI-R18 polymer
The successful escape of plasmid DNA from the endosome of cell is the premise of transfec-
tion, in consequence, the buffering capacity of the gene vector related to the escape process is
of great concern. Fig 4 showed that compared with pure water the polymer OTMCS-PEI-R18
Fig 2. 1H NMR spectra of (A) OTMCS-PEI and OTMCS-PEI-R18.
doi:10.1371/journal.pone.0166673.g002
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had relatively high buffer capability especially in the pH range of 3–7. The proton sponge of
the polymers ensures buffering inside the endosome, resulting in the degradation of lysosome
so that the DNA can be released in time. OTMCS-PEI-R18 is sufficiently suitable for gene
transfection.
Fig 3. MALDI-TOF mass spectra of (A) OTMCS-PEI and (B) OTMCS-PEI-R18.
doi:10.1371/journal.pone.0166673.g003
A Biodegradable Gene Vector for In Vivo Gene Transfection
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Particle size and Zeta potential measurements
A successful gene delivery system requires that DNA must be condensed by polycation into
nanoparticles small enough to facilitate cellular uptake [32]. The particle size and zeta potential
of OTMCS-PEI-R18/DNA were measured at different w/w ratios. As shown in Fig 5A, the par-
ticle size of complexes OTMCS-PEI-R18/DNA decreased as the increasing of w/w ratio. Both
polyplexes could condense DNA with a mean size of 100–300nm, which is suitable for efficient
gene delivery.
The surface charges on the polymer/DNA nanoparticles were represented by the zeta
potential, and a suitable cationic charge on the nanoparticles can electrostatically intect with
anion charged cellular membranes to promote complexes enter cells. As Fig 5B showed, the
zeta potential of OTMCS-PEI-R18/DNA complexes increased from 5 to 40 mV with an
increasing of w/w ratio. In addition, OTMCS-PEI-R18-l had a higher zeta potential as com-
pared with the other polymer at any designed ratio, probably because of the linking of less
peptides.
Condensation status of plasmid DNA by OTMCS-PEI-R18
Agarose gel retardation experiments was adopted to determine DNA condensation capacity of
OTMCS-PEI-R18. DNA condensates were prepared at a DNA concentration of 25 ng/μL with
polymers at various weight ratios. Complexes solutions were remained at 4˚C for 30 min
Fig 4. Determination of buffering capacity of the OTMCS-PEI-R18 polymer by acid-base titration. Solution
containing the polymer (0.2 mg/mL) was adjusted to pH 10.0, and then titrated with HCl from 10.0 to 3.0.
doi:10.1371/journal.pone.0166673.g004
A Biodegradable Gene Vector for In Vivo Gene Transfection
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Fig 5. Particle size and Zeta potential of OTMCS-PEI-R18/DNA at various w/w ratios. The average
diameter gradually decreased (A) and the Zeta potential gradually increased (B) as the ratio of conjugated
DNA increased.
doi:10.1371/journal.pone.0166673.g005
A Biodegradable Gene Vector for In Vivo Gene Transfection
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before electrophoresis. As it shown in Fig 6A and 6B, the movement of the plasmid DNA in the
gel was blurry and retarded as proportion of the polymers increased due to the polymers bind
to DNA and neutralize its charge. When DNA was coated by cationic polymer completely, the
complexes would be electroneutral or even electropositive and stop shifting to the anode. In this
experiment, the polymer of OTMCS-PEI-R18-l was able to condense DNA at a w/w ratio of 0.8
effectively while the other polymer of OTMCS-PEI-R18-h was at a w/w ratio of 2.0.
Protection of OTMCS-PEI-R18 on plasmid DNA
Considering the complex environment in vivo, protection of loaded DNA against degradation
is the premise of efficient transfection. So the stability of OTMCS-PEI-R18/DNA (w/w ratio of
20) condensates was determined by incubating them in DNase I and sodium heparin with
increasing concentrations in vitro, respectively. After exposed to DNase I, the DNA protected
by polymer was released by sodium heparin. As the Fig 6C showed, polymer could protect
OTMCS-PEI-R18/DNA condensates from enzymatic DNase I digestion well, even when the
concentration up to 63 U DNase I/μg DNA, partial DNA was still protected. Under the same
experimental conditions, naked DNA was digested by DNase I at the concentration of 0.08 U
DNase I/μg DNA [35].
Fig 6. Agarose gel electrophoresis of plasmid DNA and OTMCS-PEI-R18 /DNA complexes. Agarose gel
electrophoresis of OTMCS-PEI-R18-h/DNA(A) and OTMCS-PEI-R18-l/DNA(B) complexes at various w/w ratios,
respectively. (C) Protection of plasmid DNA from degradation by DNase I at different concentrations of 0, 3, 6, 9, 18,
27, 36, 45, 54 and 63 U DNase I/μg DNA. (D) Protection of plasmid DNA from dissociation by sodium heparin at
varying concentrations of 300, 400, 500, 600, 700, 800, 900, 1000, 1100, 1200 μg/mL.
doi:10.1371/journal.pone.0166673.g006
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Sodium heparin was used to simulate molecules with negative charges in vivo, which disso-
ciate cationic polymer with its negative charges. As Fig 6D showed, plasma DNA from poly-
mer/DNA condensates remained undetectable by agarose gel electrophoresis when incubated
with sodium heparin at a concentration lower than 500 mg/mL. OTMCS-PEI-R18 /DNA were
not completely dissociated until the concentration exceeded 1200 mg/mL.
These results demonstrated that OTMCS-PEI-R18 protected DNA from dissociation by
DNase I and negative charged molecular.
Degradation and Cytotoxicity assay
The cytotoxicity was found to be affected by molecular weight of polymers, resulting that the
HMW PEI was limited in transfection due to its high cytotoxicity. That is good degradation of
gene delivery polymers in vivo is very important for safe gene transfection. The degradation
ability of OTMCS-PEI-R18 was shown in Fig 7A. OTMCS-PEI-R18 was degraded slowly and
the degradation was nearly completed after about 60 h.
The goal of our study was to proceed a gene delivery system with efficient transfection and
low cytotoxicity. In this paper, cytotoxicity of OTMCS-PEI-R18 was analyzed in Hela cells by
MTT assay, and OTMCS-PEI, OTMCS-PEI-R13, PEI 25 KDa were performed as controls. Fig
7B showed the cell viability after incubation with polymer for 72 h as the concentration in-
creasing from 4 μg/mL to 32 μg/mL. Cell viability of OTMCS-PEI-R18 was much higher than
PEI 25 KDa, and similar to OTMCS-PEI, OTMCS-PEI-R13 at any concentration (P<0.01). In
addition, OTMCS-PEI-R18 showed litter cytotoxicity (cell viability remained > 60%) when at
a high concentration as 32 μg/mL. At the same time, cell viability decreased as the concentra-
tion increase, demonstrating it’s a typically dose-dependent process, so the application of the
polymer had better be controlled in a range of proper concentration. The low cytotoxicity of
these three polymers may be attributed to the degradation of polymers under physiological
conditions.
In vitro transfection efficiency
pEGFP-N2 and pGL3-Control were used to evaluate gene transfection of the newly synthe-
sized OTMCS-PEI-R18 polymer. Fig 8A displayed representative fluorescence images of Hela
Fig 7. The cytotoxicity of OTMCS-PEI-R18. (A) Degradation of OTMCS-PEI-R18. (B) Cytotoxicity of
OTMCS-PEI-R18 and other PEI derivates at various concentrations in Hela cell line using the MTT assay.
OTMCS-PEI-R13, OTMCS-PEI and PEI 25 KDa were used as controls.
doi:10.1371/journal.pone.0166673.g007
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cells transfected by OTMCS-PEI-R18/pEGFP-N2 at weight ratio range from 5 to 30. Accord-
ing to these images, the pEGFP-N2 reporter gene was effectively transfected into Hela cells.
The percentage of green fluorescence positive cells was proportional to the w/w ratio of
OTMCS-PEI-R18/DNA and the highest proportion of green fluorescence positive cells was
observed at the weight ratio of 30.
Fig 8B showed the gene transfection efficiency of OTMCS-PEI-R18/pGL3-Control com-
plexes in Hela cells in comparison with other polymers. OTMCS-PEI-R18/DNA complexes
displayed much higher transfection level than other complexes at any designed weight ratio.
The highest luciferase expression delivered by OTMCS-PEI-R18 was almost 5 times as OTMC-
S-PEI-R13, 102 times as OTMCS-PEI and even 104 times as PEI 25 KDa. OTMCS-PEI-R18-l
and OTMCS-PEI-R18-h both revealed that maximal transfection efficiency at high weight
ratio (almost at the concentration of 75μg/mL). Moreover, significant enhancement of lucifer-
ase expression was observed as the raw ratio of R18 increased, which demonstrated that the
addition of R18 considerably enhanced the uptake of the polymer-delivered DNA.
Nuclear transport evaluation
To visually reveal intracellular fate of OTMCS-PEI-R18 at different time points, Hela cells were
treated with the FITC-labeled OTMCS-PEI-R18/DNA complexes. Here, DNA was non-func-
tional plasmid used to help polymer to form the condensed nanoparticles. The results were
shown in Fig 9A, FITC-labeled OTMCS-PEI-R18 was shown in green, the nuclear stained with
HE was blue. After incubation for 30 min, mainly FITC-labeled OTMCS-PEI-R18/DNA com-
plexes distributed in the cytoplasm and a few had entered into nucleus. At next time point for
1 h, large amount of green accumulated in the nucleus and it is obviously that, more green
accumulation was observed in the nucleus treated for 2 h in comparison with treated for 1 h.
Nuclear membrane is one of the barriers at gene delivery system which was needed to overcome
for efficient transfection. It is proved that OTMCS-PEI-R18 could deliver plasmid DNA into
nucleus well soon, which is prerequisite for gene therapy, and chemical inhibitors specific to
Fig 8. Gene transfection efficiency of OTMCS-PEI-R18/DNA polyplexes. (A) Representative fluorescence
images for transfection in Hela cells using OTMCS-PEI-R18 at w/w ratios of 5, 10, 20, and 30. (B) Transfection
efficiency of OTMCS-PEI-R18/DNA complexes in Hela cell line at w/w ratios of 5, 10, 20, and 30.
doi:10.1371/journal.pone.0166673.g008
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Fig 9. The intracellular distribution of complexes OTMCS-PEI-R18/DNA. (A) Fluorescent confocal
microscopic images of Hela cells treated with FITC-labeled OTMCS-PEI-R18 polyplexes for 0.5 h, 1 h and 2 h,
where the FITC-labeled OTMCS-PEI-R18 was shown in green, and the HE stained nuclear was shown in blue.
(B) Inhibitory effect of different concentrations of Paclitaxel (PTX), Colchicine (Col) and Acrylamide on
transfection efficiency of OTMCS-PEI-R18/DNA complex in Hela cells at w/w ratio of 30. The RLU/mg protein in
control cells was set to 100%.
doi:10.1371/journal.pone.0166673.g009
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microtubules and intermediate filaments were used to investigate whether it is due to the con-
junction of NLS.
Microtubules and intermediate filaments are basic cytoskeletons of the cell. Microtubules
play important roles in mitosis, and intermediate filaments are closely related to microtubules,
might contribute to the stability and assembly of microtubules. Colchicine (Col) and paclitaxel
(PTX) were used as inhibitors of microtubules. Col caused depolymerization of microtubules,
but PTX was shown to bind to tubulin and stimulate excessive microtubules stabilization.
Acrylamide was used to study intermediate filaments. All of them would disrupt the mitosis in
cell division phase. OTMCS-PEI-R13, OTMCS-PEI were performed as controls. In Fig 9B, the
effect of inhibition was more obvious for OTMCS-PEI and OTMCS-PEI-R13. Compared with
the blank control groups, gene transfection efficiency of OTMCS-PEI without ligand modifica-
tion decreased nearly 80%, and even up to 90% when treated with 20 μg Col. The inhibitory
effect on transfection of OTMCS-PEI-R13 was weakened in the presence of TAT peptide, but
still be suppressed by almost 50%. By contrast, the weakest inhibition was showed for OTMC-
S-PEI-R18 and the inhibitory rate was just about 20% when treated with 20 μg Col. It proved
that the nuclear transport of OTMCS-PEI-R18/DNA may not rely on cell division completely
and the introduction of NLS facilitated the transport process. DNA nanoparticles always
get into the nucleus during mitosis of the cell in vitro, the introduction density of OTMC-
S-PEI-R13/DNA and OTMCS-PEI/DNA without modification of NLS sharply decreased after
the inhibition of cell division, while OTMCS-PEI-R18/DNA complexes could transport into
nucleus under the NLS mediated through NPC (nuclear pore complex), which is advantageous
for gene transfection in vivo.
In vivo transfection efficiency
Efficient delivery system for therapeutic genes with least side effects would have great potential
in clinical treatment. In order to research the delivery capacity of OTMCS-PEI-R18 in vivo,
complexes (polymer/pGL3-Control) containing 30 mg of plasmid DNA prepared at w/w ratio
of 30 were tail intravenously injected into Hela tumor-bearing nude mice, and OTMCS-PEI-
R13, OTMCS-PEI, PEI 25 KDa were used as controls. As Fig 10, complex OTMCS-PEI-R18-
marker in vivo gene transfection exhibited higher luciferase expression level in any tissues
compared with OTMCS-PEI-R13, OTMCS-PEI and PEI 25 KDa. For PEI 25 KDa and OTMC-
S-PEI, expression level in tumor was lower than that in lung due to nonspecific adsorption,
but with the modification of peptide R13, tumor expression of OTMCS-PEI-R13 enhanced
and basically equal to lung, proving tumor targeting capabilities of pepetide R13. Further, sig-
nificantly higher expression in tumor was observed after the introduction of NLS peptide,
almost 12-fold increase in luciferase activity compared with OTMCS-PEI-R13. Gene expres-
sion of both OTMCS-PEI-R18-l/DNA and OTMCS-PEI-R18-h/DNA complexes was highest
in the tumor, and OTMCS-PEI-R18-h showed higher luciferase expression. This phenomenon
is absolutely consistent with the previous study, which further proved the ability of facilitating
nucleus import of the new attached NLS peptide.
Conclusion
We developed a new non-viral gene vector OTMCS-PEI-R18 by cross-linking LMW PEI with
OTMCS and further coupled with a trifunctional peptide R18 for specific tumor targeting, cel-
lular and nucleus transport. Through characterization of its chemical structure and biophysical
parameters, the polymer OTMCS-PEI-R18-l could condense plasmid DNA to nanoparticle at
the weight ratio about 0.8. In addition, the new polyplexes could efficiently DNA into stable
nanoparticle with proper size and zeta potential. The nanoparticle could resist dissociation by
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DNase I at a concentration of 63U DNase I/DNA and dissociation induced by 1200 μg/mL
sodium heparin, it also showed controlled degradation, high buffer capabilities and low cyto-
toxicity. These means the polymer absolutely proper as a gene vector for in vivo application.
The gene vector system OTMCS-PEI-R18 displayed better transfection rates as compared to
polymers OTMCS-PEI-R13, OTMCS-PEI and PEI 25 KDa in vitro and in vivo, due to the
newly incorporated ligand peptide NLS with the properties of promoting nuclear delivery.
Images got by a confocal fluorescence microscope proved that after taking up by the cells, the
complexes accumulated in the nucleus eventually. In addition, the study on nuclear transport
also proved that introduction of NLS facilitated the nuclear transport of OTMCS-PEI-R18/
DNA. In conclusion, this new polymer OTMCS-PEI-R18 may act as promising candidates for
non-viral gene delivery in future in vivo application with low cytotoxicity and high transfec-
tion efficiency. We are recently carrying out more comprehensive studies with the aim of
exploring the nuclear transport pathway of OTMCS-PEI-R18.
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